Literature DB >> 7734147

Osteogenic protein-1 (OP-1) expression and processing in Chinese hamster ovary cells: isolation of a soluble complex containing the mature and pro-domains of OP-1.

W K Jones1, E A Richmond, K White, H Sasak, W Kusmik, J Smart, H Oppermann, D C Rueger, R F Tucker.   

Abstract

We have characterized the expression and processing of Osteogenic Protein-1 (hOP-1), a bone morphogenic protein of the TGF-beta family, in Chinese hamster ovary cells. The hOP-1 is initially synthesized as a monomeric 50 kDa pro-protein that is dimerized, glycosylated, and then proteolytically cleaved at the Arg-Xaa-Xaa-Arg maturation site in an acidic cellular compartment before secretion into the medium. Of the four potential N-linked glycosylation sites two are used, one in the mature domain and one in the pro-domain. Gel permeation chromatography of secreted hOP-1 in physiological buffers yields an apparent molecular weight of 110-120 k, indicating that after proteolytic processing the two pro-domains remain non-covalently associated with the disulfide linked mature dimer in a complex termed soluble hOP-1. Purified soluble hOP-1 is significantly more soluble in physiological buffers than the purified mature OP-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7734147     DOI: 10.3109/08977199409046919

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  23 in total

1.  The prodomain of BMP4 is necessary and sufficient to generate stable BMP4/7 heterodimers with enhanced bioactivity in vivo.

Authors:  Judith M Neugebauer; Sunjong Kwon; Hyung-Seok Kim; Nathan Donley; Anup Tilak; Shailaja Sopory; Jan L Christian
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

2.  Alternative cleavage of the bone morphogenetic protein (BMP), Gbb, produces ligands with distinct developmental functions and receptor preferences.

Authors:  Edward N Anderson; Kristi A Wharton
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

3.  A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7.

Authors:  Gerhard Sengle; Robert N Ono; Karen M Lyons; Hans Peter Bächinger; Lynn Y Sakai
Journal:  J Mol Biol       Date:  2008-07-02       Impact factor: 5.469

4.  Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro.

Authors:  Wei Zhu; Jaehon Kim; Christina Cheng; Bernard A Rawlins; Oheneba Boachie-Adjei; Ronald G Crystal; Chisa Hidaka
Journal:  Bone       Date:  2006-02-20       Impact factor: 4.398

5.  BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.

Authors:  Jeroen T Buijs; Cyrill A Rentsch; Geertje van der Horst; Petra G M van Overveld; Antoinette Wetterwald; Ruth Schwaninger; Niek V Henriquez; Peter Ten Dijke; Fran Borovecki; Regula Markwalder; George N Thalmann; Socrates E Papapoulos; Rob C M Pelger; Slobodan Vukicevic; Marco G Cecchini; Clemens W G M Löwik; Gabri van der Pluijm
Journal:  Am J Pathol       Date:  2007-09       Impact factor: 4.307

6.  Production, Isolation, and Structural Analysis of Ligands and Receptors of the TGF-β Superfamily.

Authors:  Tao Huang; Andrew P Hinck
Journal:  Methods Mol Biol       Date:  2016

7.  Expression and synthesis of bone morphogenetic proteins by osteoclasts: a possible path to anabolic bone remodeling.

Authors:  Rama Garimella; Sarah E Tague; Jianghong Zhang; Frank Belibi; Niru Nahar; Ben Hua Sun; Karl Insogna; Jinxi Wang; H Clarke Anderson
Journal:  J Histochem Cytochem       Date:  2008-03-03       Impact factor: 2.479

8.  Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7).

Authors:  S Vukicevic; J B Kopp; F P Luyten; T K Sampath
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

9.  BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways.

Authors:  W A Grasser; I Orlic; F Borovecki; K A Riccardi; P Simic; S Vukicevic; V M Paralkar
Journal:  Int Orthop       Date:  2007-07-19       Impact factor: 3.075

Review 10.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.